Depression and parkinson's disease: A review

American Journal of Psychiatry

Volumn 149, Issue 4, 1992, Pages 443-454

  Cummings, Jeffrey L ^a,b  

^a School of Medicine ^*

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; BIOLOGICAL MARKER; TRICYCLIC ANTIDEPRESSANT AGENT;

CLINICAL FEATURE; DEPRESSION; DISEASE COURSE; DOPAMINERGIC SYSTEM; ELECTROCONVULSIVE THERAPY; FRONTAL LOBE; HUMAN; MOOD; NEUROPATHOLOGY; NEUROPSYCHIATRY; NORADRENERGIC SYSTEM; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STRESS;

BIOLOGICAL MARKERS; DEPRESSIVE DISORDER; DOPAMINE; FEMALE; FRONTAL LOBE; HUMAN; HYDROXYINDOLEACETIC ACID; LATERALITY; MALE; MODELS, NEUROLOGICAL; MODELS, PSYCHOLOGICAL; NOREPINEPHRINE; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026582759     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.149.4.443     Document Type: Article

References (99)

1. Parkinson Study Group: Effect of deprenyl on the progression of disability in early Parkinson's disease. N Engl J Med 1989; 321:1364-1371
2. Lindvall O, Rehncrona S, Brundin P, Gustavii B, Astedt B, Widner H, Lindholm T, Bjorklund A, Leenders KL, Trothwell JC, Frackowiak R, Marsden CD, Johnels B, Steg G, Freedman R, Hoffer BJ, Seiger A, Bygdeman M, Stromberg I, Olson L: Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. Arch Neurol 1989; 46:615-631
3. Patrick HT, Levy DM: Parkinson's disease: a clinical study of 146 cases. Arch Neurol Psychiatry 1922; 7:711-720
4. Mjones H: Paralysis agitans. Acta Psychiatr Neurol Suppl 1949; 54:1-195
5. Strang RR: Imipramine in treatment of parkinsonism: a double-blind placebo study. Br Med J 1965; 2:33-34
6. Hoehn MM, Yahr MD: Parkinsonism: onset, progression, and mortality. Neurology 1967; 17:427-442
7. Warburton JW: Depressive symptoms in Parkinson patients referred for thalamotomy. J Neurol Neurosurg Psychiatry 1967; 30:368-370
8. Celesia GG, Wanamaker WM: Psychiatric disturbances in Parkinson's disease. Dis Nerv Syst 1972; 33:577-583
9. Brown GL, Wilson WP: Parkinsonism and depression. South Med J 1972; 65:540-545
10. Mindham RHS, Marsden CD, Parkes JD: Psychiatric symptoms during Ldopa therapy for Parkinson's disease and their relationship to physical disability. Psychol Med 1976; 6:23-33
11. Lesser RP, Fahn S, Snider SR, Cote LJ, Isgreen WP, Barrett RE: Analysis of the clinical problems in parkinsonism and the complications of long-term levodopa therapy. Neurology 1979; 29(9, part 1):1253-1260
12. Lieberman A, Dziatolowski M, Kupersmith M, Serby M, Goodgold A, Korein J, Goldstein M: Dementia in Parkinson disease. Ann Neurol 1979; 6:355-359
13. Presthus J: Psychiatric side-effects occurring in parkinsonism during long-term treatment with levodopa alone and in combination with other drugs, in Parkinson's Disease: Current Progress, Problems, and Management. Edited by Rinne UK, Klinger M, Stamm G. New York, Elsevier/North Holland, 1980
14. Mayeux R, Stern Y, Rosen J, Leventhal J: Depression, intellectual impairment, and Parkinson disease. Neurology 1981; 31:645-650
15. Gotham AM, Brown RG, Marsden CD: Depression in Parkinson's disease: a quantitative and qualitative analysis. J Neurol Neurosurg Psychiatry 1986; 49:381-389
16. Santamaria J, Tolosa E, Valles A: Parkinson's disease with depression: a possible subgroup of idiopathic parkinsonism. Neurology 1986; 36:1130-1133
17. Mayeux R, Stern Y, Williams JBW, Cote L, Frantz A, Dyrenfurth I: Clinical and biochemical features of depression in Parkinson's disease. Am J Psychiatry 1986; 143:756-759
18. Oyebode JR, Barker WA, Blessed G, Dick DJ, Britton PG: Cog-nitive functioning in Parkinson's disease: in relation to prevalence of dementia and psychiatric diagnosis. Br J Psychiatry 1986; 149:720-725
19. Taylor AE, Saint-Cyr JA, Lang AE, Kenny FT: Parkinson's disease and depression: a critical re-evaluation. Brain 1986; 109:279-292
20. Kostic VS, Djuricic BM, Covickovic-Sternic N, Bumbasirevic L, Nikolic M, Mrsulja BB: Depression and Parkinson's disease: possible role of serotonergic mechanisms. J Neurol 1987; 234:94-96
21. Huber SJ, Paulson GW, Shuttleworth EC: Depression in Parkinson's disease. Neuropsychiatry, Neuropsychology, and Behavioral Neurology 1988; 1:47-51
22. Brown RG, MacCarthy B, Gotham AM, Der GJ, Marsden CD: Depression and disability in Parkinson's disease: a follow-up study of 132 cases. Psychol Med 1988; 18:49-55
23. Darkins AW, Fromkin VA, Benson DF: A characterization of the prosodic loss in Parkinson's disease. Brain Lang 1988; 34:315-327
24. Bieliauskas LA, Glantz RH: Depression type in Parkinson's disease. J Clin Exp Neuropsychol 1989; 11:597-604
25. Sano M, Stern Y, Williams J, Cote L, Rosenstein R, Mayeux R: Coexisting dementia and depression in Parkinson's disease. Arch Neurol 1989; 46:1284-1286
26. Starkstein SE, Preziosi TJ, Bolduc PL, Robinson RG: Depression in Parkinson's disease. J Nerv Ment Dis 1990; 178:27-31
27. Brown RG, MacCarthy B: Psychiatric morbidity in patients with Parkinson's disease. Psychol Med 1990; 20:77-87
28. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-571
29. Direnfeld LK, Albert ML, Volicer L, Langlais PJ, Marquis J, Kaplan E: Parkinson's disease: the possible relationship of laterality to dementia and neurochemical findings. Arch Neurol 1984; 41:935-941
30. Stern Y, Mayeux R, Rosen J: Contribution of perceptual motor dysfunction to construction and tracing disturbances in Parkinson's disease. J Neurol Neurosurg Psychiatry 1984; 47:983-989
31. Freedman M, Oscar-Berman M: Selective delayed response deficits in Parkinson's disease and Alzheimer's disease. Arch Neurol 1986; 43:886-890
32. Levin BE, Llabre MM, Weiner WJ: Parkinson's disease and depression: psychometric properties of the Beck Depression Inventory. J Neurol Neurosurg Psychiatry 1988; 51:1401-1404
33. Huber SJ, Freidenberg DL, Shuttleworth EC, Paulson GW, Christy JA: Neuropsychological impairments associated with severity of Parkinson's disease. J Neuropsychiatry Clin Neurosciences 1989; 1:154-158
34. Gibb WRG, Lees AJ: A comparison of clinical and pathological features of young- and old-onset Parkinson's disease. Neurology 1988; 38:1402-1406
35. Spicer KB, Roberts RJ, Le Witt PA: Neuropsychological performance in lateralized parkinsonism. Arch Neurol 1988; 45: 429-432
36. Huber SJ, Freidenberg DL, Shuttleworth EC, Paulson GW, Clapp LE: Neuropsychological similarities in lateralized parkinsonism. Cortex 1989; 25:461-470
37. Beatty WW, Staton RD, Weir WS, Monson N, Whitaker HA: Cognitive disturbances in Parkinson's disease. J Geriatr Psychiatry Neurol 1989; 2:22-33
38. Ehmann TS, Beninger RJ, Gawel MJ, Riopelle RJ: Depressive symptoms in Parkinson's disease: a comparison with disabled control subjects. J Geriatr Psychiatry Neurol 1990; 2:3-9
39. Huber SJ, Freidenberg DL, Paulson GW, Shuttleworth EC, Christy JA: The pattern of depressive symptoms varies with progression of Parkinson's disease. J Neurol Neurosurg Psychiatry 1990; 53:275-278
40. Starkstein SE, Preziosi TJ, Forrester AW, Robinson RG: Specificity of affective and autonomic symptoms of depression in Parkinson's disease. J Neurol Neurosurg Psychiatry 1990; 53:869-873
41. Horn S: Some psychological factors in parkinsonism. J Neurol Neurosurg Psychiatry 1974; 37:27-31
42. Dubois B, Pillon B, Sternic N, Lhermitte F, Agid Y: Age-induced cognitive disturbances in Parkinson's disease. Neurology 1990; 40:38-41
43. Ludin SM, Ludin HP: Is Parkinson's disease of early onset a separate disease entity? J Neurol 1989; 236:203-207
44. Starkstein SE, Berthier ML, Bolduc PL, Preziosi TJ, Robinson RG: Depression in patients with early versus late onset of Parkinson's disease. Neurology 1989; 39:1441-1445
45. Mayeux R, Stern Y, Cote C, Williams JB: Altered serotonin metabolism in depressed patients with Parkinson's disease. Neurology 1984; 34:642-646
46. Robins AH: Depression in patients with parkinsonism. Br J Psychiatry 1976; 128:141-145
47. Singer E: The effect of treatment with levodopa on parkinson patients' social functioning and outlook on life. J Chronic Dis 1974; 27:581-594
48. Schiffer RB, Kurlan R, Rubin A, Boer S: Evidence for atypical depression in Parkinson's disease. Am J Psychiatry 1988; 145: 1020-1022
49. Mayeux R, Stern Y, Sano M, Williams JB, Cote LJ: The relationship of serotonin to depression in Parkinson's disease. Mov Disord 1988; 3:237-244
50. Pfeiffer RF, Hsieh HH, Diercks MJ, Glaeske C, Jefferson A, Cheng SC: Dexamethasone suppression test in Parkinson's disease. Adv Neurol 1987; 45:439-442
51. Frochtengarten ML, Villares JCB, Maluf E, Carlini EA: Depressive symptoms and the dexamethasone suppression test in parkinsonian patients. Biol Psychiatry 1987; 22:386-389
52. Kuhn W, Fuchs G, Laux G, Rupprecht R, Przuntek H: Clinical and biochemical characteristics of early depression in Parkinson's disease, in Early Diagnosis and Preventive Therapy in Parkinson's Disease. Edited by Przuntek H, Riederer P. New York, Springer-Verlag, 1989
53. Kostic VS, Covickovic-Sternic N, Beslac-Bumbasirevic L, Ocic G, Pavlovic D, Nikolic M: Dexamethasone suppression test in patients with Parkinson's disease. Mov Disord 1990; 5:23-26
54. Rabey JM, Scharf M, Oberman Z, Zohar M, Graff E: Cortisol, ACTH, and beta-endorphin after dexamethasone administration in Parkinson's dementia. Biol Psychiatry 1990; 27:581-591
55. Mayberg HS, Starkstein SE, Sadzot B, Preziosi T, Andrezejewski PL, Dannals RF, Wagner HN Jr, Robinson RG: Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease. Ann Neurol 1990; 28:57-64
56. Baxter LR Jr, Schwartz JM, Phelps ME, Mazziotta JC, Guze BH, Selin CE, Gerner RH, Sumida RM: Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 1989; 46:243-250
57. Kostic VS, Susic V, Przedborski S, Sternic N: Sleep EEC in depressed and nondepressed patients with Parkinson's disease. J Neuropsychiatry Clin Neurosciences 1991; 3:176-179
58. Chan-Palay V, Asan E: Alterations in catecholamine neurons of the locus ceruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression. J Comp Neurol 1989; 287:373-392
59. Torack RM, Morris JC: The association of ventral tegmental area histopathology with adult dementia. Arch Neurol 1988; 45: 497-501
60. D'Amato RJ, Zweig RM, Whitehouse PJ, Wenk GL, Singer HS, Mayeux R, Price DL, Snyder SH: Aminergic systems in Alzheimer's disease and Parkinson's disease. Ann Neurol 1987; 22: 229-236
61. Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, Golbe L, Huber S, Koller W, Olanow C, Shoulson I, Stern M, Tanner C, Weiner W, Parkinson Study Group: Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. Neurology 1990; 40:1529-1534
62. Barber J, Tomer R, Sroka H, Myslobodsky MS: Does unilateral dopamine deficit contribute to depression? Psychiatr Res 1985; 15:17-24
63. Huber SJ, Shuttleworth EC, Paulson GW: Dementia in Parkinson's disease. Arch Neurol 1986; 43:987-990
64. Cummings JL: Intellectual impairment in Parkinson's disease: clinical, pathologic, and biochemical correlates. J Geriatr Psychiatry Neurol 1988; 1:24-36
65. Starkstein SE, Rabins PV, Berthier ML, Cohen BJ, Folstein MF, Robinson RG: Dementia of depression among patients with neurological disorders and functional depression. J Neuropsychiatry Clin Neurosciences 1989; 1:263-268
66. Rogers D, Lees AJ, Smith E, Trimble M, Stern GM: Bradyphrenia in Parkinson's disease and psychomotor retardation in depressive illness: an experimental study. Brain 1987; 110:761-776
67. Brown RG, Marsden CD, Quinn N, Wyke MA: Alterations in cognitive performance and affect-arousal during fluctuations in motor function in Parkinson's disease. J Neurol Neurosurg Psychiatry 1984; 47:454-465
68. Cantello R, Gilli M, Riccio A, Bergamasco B: Mood changes associated with "end-of-dose deterioration" in Parkinson's disease: a controlled study. J Neurol Neurosurg Psychiatry 1986; 49:1182-1190
69. Freidenberg DL, Cummings JL: Parkinson's disease, depression, and the on-off phenomenon. Psychosomatics 1989; 30:94-99
70. Girotti F, Carella F, Pia Grassi M, Soliveri P, Marano R, Caraceni T: Motor and cognitive performances of parkinsonian patients in the on and off phases of the disease. J Neurol Neurosurg Psychiatry 1986; 49:657-660
71. Hardie RJ, Lees AJ, Stern GM: On-off fluctuations in Parkinson's disease. Brain 1984; 107:487-506
72. Nissenbaum H, Quinn NP, Brown RG, Toone B, Gotham AM, Marsden CD: Mood swings associated with the "on-off" phenomenon in Parkinson's disease. Psychol Med 1987; 17:899-904
73. Menza MA, Sage J, Marshall E, Cody R, Duvoisin R: Mood changes and "on-off" phenomena in Parkinson's disease. Mov Disord 1990; 5:148-151
74. Jouvent R, Abensour P, Bonnet AM, Widlocher D, Agid Y, Lhermitte F: Antiparkinsonian and antidepressant effects of high doses of bromocriptine: an independent comparison. J Affective Disord 1983; 5:141-145
75. Ruggieri S, Stocchi F, Denaro A, Baronti F, Agnoli A: The role of MAO-B inhibitors in the treatment of Parkinson's disease. J Neural Transm Suppl 1986; 22:227-233
76. Birkmayer W: Deprenyl (selegiline) in the treatment of Parkinson's disease. Acta Neurol Scan 1983; Suppl 95:103-106
77. Goetz CG, Tanner CM, Penn RD, Stebbins GT III, Gilley DW, Shannon KM, Klawans HL, Comella CL, Wilson RS, Witt T: Adrenal medullary transplant to the striatum of patients with advanced Parkinson's disease: 1-year motor and psychomotor data. Neurology 1990; 40:273-276
78. Andersen J, Aabro E, Gulmann N, Hjelmsted A, Pedersen HE: Anti-depressive treatment in Parkinson's disease: a controlled trial of the effect of nortriptyline in patients with Parkinson's disease treated with L-dopa. Acta Neurol Scand 1980; 62:210-219
79. Laitinen L: Desipramine in treatment of Parkinson's disease. Acta Neurol Scand 1969; 45:109-113
80. Goetz GG, Tanner CM, Klawans HL: Bupropion in Parkinson's disease. Neurology 1984; 34:1092-1094
81. Cantello R, Aguggia M, Gilli M, Delsedime M, Chiardo-Cutin I, Riccio A, Mutani R: Major depression in Parkinson's disease and the mood response to intravenous methylphenidate: possible role of the "hedonic" dopamine synapse. J Neurol Neurosurg Psychiatry 1989; 52:724-731
82. Young RC, Alexopoulos GS, Shamoian CA: Dissociation of motor response from mood and cognition in a parkinsonian patient treated with ECT. Biol Psychiatry 1985; 20:566-569
83. Burke WJ, Peterson J, Rubin EH: Electroconvulsive therapy in the treatment of combined depression and Parkinson's disease. Psychosomatics 1988; 29:341-346
84. Asnis G: Parkinson's disease, depression, and ECT: a review and case study. Am J Psychiatry 1977; 134:191-195
85. Douyon R, Serby M, Klutchko B, Rotrosen J: ECT and Parkinson's disease revisited: a "naturalistic" study. Am J Psychiatry 1989; 146:1451-1455
86. Lebensohn ZM, Jenkins RB: Improvement of parkinsonism in depressed patients treated with ECT. Am J Psychiatry 1975; 132:283-285
87. Yudofsky SC: Parkinson's disease, depression, and electroconvulsive therapy: a clinical and neurobiologic synthesis. Compr Psychiatry 1979; 20:579-581
88. Dysken M, Evans HM, Chan CH, Davis JM: Improvement of depression and parkinsonism during ECT: a case study. Neuropsychobiology 1976; 2:81-86
89. Jellinger K: Overview of morphological changes in Parkinson's disease. Adv Neurol 1986; 45:1-18
90. Javoy-Agid F, Agid Y: Is the mesocortical dopaminergic system involved in Parkinson disease? Neurology 1980; 30:1326-1330
91. Hornykiewicz O, Kish SJ: Biochemical pathophysiology of Parkinson's disease. Adv Neurol 1986; 45:19-34
92. Hornykiewicz O: Biochemical abnormalities in some extrastriatal neuronal systems in Parkinson's disease, in Parkinson's Disease: Current Progress, Problems, and Management. Edited by Rinne UK, Klinger M, Stamm G. New York, Elsevier/North Holland, 1980
93. Barbeau A: Parkinson's disease: clinical features and etiopathology, in Handbook of Clinical Neurology, vol 5(49): Extrapyramidal Disorders. Edited by Vinken PJ, Bruyn GW, Klawans HL. New York, Elsevier, 1986
94. 3H-paroxetine binding sites in putamen. Neurology 1986; 36:556-560
95. Javoy-Agid F, Ruberg M, Hirsch E, Cash R, Raisman R, Taquet H, Epelbaum J, Scatton B, Duyckaerts C, Agid Y: Recent progress in the neurochemistry of Parkinson's disease, in Recent Developments in Parkinson's Disease. Edited by Fahn S, Marsden CD, Jenner P, Teychenne P. New York, Raven Press, 1986
96. Glowinski J, Tassin JP, Thierry AM: The mescortical-prefrontal dopaminergic neurons. Trends Neurosci 1984; 7:415-418
97. Febiger HC: The neurobiological substrates of depression in Parkinson's disease: a hypothesis. Can J Neurol Sci 1984; 11:105-107
98. Taylor AE, Saint-Cyr JA: Depression in Parkinson's disease: reconciling physiological and psychological perspectives. J Neuropsychiatry Clin Neurosciences 1990; 2:92-98
99. Ehmann TS, Beninger RJ, Gawel MJ, Riopelle RJ: Coping, social support, and depressive symptoms in Parkinson's disease. J Geriatr Psychiatry Neurol 1990; 3:85-90